IGF1 and hypopituitarism: Furthermore, in agreement with the report by Webb and colleagues [30], the rate of complete hypopituitarism recovery in patients with GH releasing tumor was greater than in the other patients (4/7); these patients were typically younger, and both the hormonal therapy before surgery and their high IGF-1 levels helped to preserve pituitary gland activity.